FFCP PHASE1:Hg19::chr19:10305581..10305646,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@DNMT1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_DNMT1_5end |
Coexpression cluster: | C1011_acute_granulocyte_Hodgkin_neuroepithelioma_retinoblastoma_hepatoblastoma_merkel |
Association with transcript: | 108bp_to_ENST00000340748, ENST00000359526, ENST00000540357, NM_001130823, NM_001379, uc002mng.2, uc002mnh.2, uc010xlc.1, uc010xld.1_5end |
EntrezGene: | DNMT1 |
HGNC: | 2976 |
UniProt: | P26358F5GX68 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@DNMT1 |
---|
0
100
200
300
400
500
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.57e-36 | 235 |
disease of cellular proliferation | 4.58e-35 | 239 |
hematologic cancer | 1.27e-24 | 51 |
immune system cancer | 1.27e-24 | 51 |
leukemia | 1.03e-21 | 39 |
organ system cancer | 5.36e-18 | 137 |
myeloid leukemia | 2.00e-17 | 31 |
cell type cancer | 1.87e-15 | 143 |
carcinoma | 3.42e-11 | 106 |
Showing 1 to 9 of 9 entries